Rachelle is currently completing her PhD which was funded by an Alzheimer’s Research UK Clinical Research Fellowship. She qualified in Medicine from UCL Medical School and is currently taking time out from her neurology training in London. Her research focused on developing new biomarkers to try to identify the presence of TDP-43 or associated proteins such as stathmin-2 and PPIA in the blood or spinal fluid of people with FTD.
- ABN Annual Meeting (Edinburgh, May 2019): Proteomic analysis of TDP-43 pathology in frontotemporal dementia
- 11th ICFTD (Sydney, November 2018): Two pathologically-confirmed cases of novel mutations in the MAPT gene causing behavioural variant frontotemporal dementia
- ARUK Conference 2018 (London, March 2018): Identification of biofluid markers of TDP-43 pathology
- Two pathologically confirmed cases of novel mutations in the MAPT gene causing frontotemporal dementia. Shafei R, Woollacott IOC, Mummery C, Bocchetta M, Guerreiro R, Bras J, Warren JD, Lashley T, Jaunmuktane Z, Rohrer JD. Neurobiol Aging. 2020;87:141.e15-141.e20.